Mayo, Muiz U.

HRN: 20-92-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2025
CEFUROXIME 750MG (VIAL)
11/17/2025
11/24/2025
IV
500mg
Q8
AGE
Checking Final Appropriateness 
11/17/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/17/2025
11/24/2025
ORAL
8ml
Q8
Amoebiasis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: